Robotic vs. Open NSM for Early Stage Breast Cancer
← catalyst calendarSponsored by Intuitive Surgical (industry) · ISRG — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
204estimated
Sites
15
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-05-08 | actual | When the study began enrolling |
| Primary completion | Mar 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Mar 2031 | estimated | The whole study's end, after follow-up |
| First posted | 2023-02-09 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-02-24 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Breast Cancer Female
- Breast Cancer
- Breast Cancer, Early-Onset
- Breast Disease
- Breast
Interventions
- Device: Robotic NSM — also filed as RNSM, SP NSM
- Procedure: Open NSM
Primary outcomes
what the primary-completion date above is the date OFConversion rate
measured Assessed during procedure
Safety: Adverse event rates
measured Up to 42 days post-operatively
Safety: positive surgical margin rates
measured Up to 42 days post-operatively
Permalink · ISRG's whole pipeline · Catalyst calendar · Every registered study · What changed